Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, A., Swedberg, K., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,234
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
Waagstein, F., Hjalmarson, A., Varnauskas, E., & Wallentin, I. (1975) · Heart · doi:10.1136/hrt.37.10.1022 · Cited by 832
PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE
Swedberg, K., Hjalmarson, A., Waagstein, F., & Wallentin, I. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92010-5 · Cited by 417
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
Chadda, K., Goldstein, S., Byington, R., & Curb, J. D. (1986) · Circulation · doi:10.1161/01.cir.73.3.503 · Cited by 403
Cited by
Items 201–300 of 324
A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure
Liggett, S. B., Cresci, S., Kelly, R. J., Syed, F. M., Matkovich, S. J., Hahn, H. S., Diwan, A., Martini, J. S., Sparks, L., Parekh, R. R., et al. (2008) · Nature Medicine · doi:10.1038/nm1750 · Cited by 319
Gender differences in the effects of cardiovascular drugs
Tamargo, J., Rosano, G., Walther, T., Duarte, J., Niessner, A., Kaski, J., Ceconi, C., Drexel, H., Kjeldsen, K., Savarese, G., et al. (2017) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvw042 · Cited by 317
Jr, A. R., Rassi, A., & Little, W. C. (2000) · Clinical Cardiology · doi:10.1002/clc.4960231205 · Cited by 317
Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials
Bangalore, S., Makani, H., Radford, M., Thakur, K., Toklu, B., Katz, S. D., DiNicolantonio, J. J., Devereaux, P. J., Alexander, K. P., Wetterslev, J., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.05.032 · Cited by 315
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2024) · European Heart Journal: Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad107 · Cited by 314
Marijon, E., Narayanan, K., Smith, K., Barra, S., Basso, C., Blom, M. T., Crotti, L., D'Avila, A., Deo, R., Dumas, F., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00875-9 · Cited by 313
Krum, H., Roecker, E. B., Mohacsi, P., Rouleau, J. L., Tendera, M., Coats, A. J. S., Katus, H. A., Fowler, M. B., Packer, M., & for the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group (2003) · JAMA · doi:10.1001/jama.289.6.712 · Cited by 310
Lancellotti, P., Pellikka, P. A., Budts, W., Chaudhry, F. A., Donal, E., Dulgheru, R., Edvardsen, T., Garbi, M., Ha, J. W., Kane, G. C., et al. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.10.016 · Cited by 310
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.023 · Cited by 309
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
Howard, B. V., Rodriguez, B. L., Bennett, P. H., Harris, M. I., Hamman, R., Kuller, L. H., Pearson, T. A., & Wylie-Rosett, J. (2002) · Circulation · doi:10.1161/01.cir.0000013953.41667.09 · Cited by 308
Haugaa, K. H., Smedsrud, M. K., Steen, T., Kongsgaard, E., Loennechen, J. P., Skjaerpe, T., Voigt, J.-U., Willems, R., Smith, G., Smiseth, O. A., et al. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.11.012 · Cited by 307
Reiken, S., Wehrens, X. H. T., Vest, J. A., Barbone, A., Klotz, S., Mancini, D., Burkhoff, D., & Marks, A. R. (2003) · Circulation · doi:10.1161/01.cir.0000068316.53218.49 · Cited by 307
Electrophysiological changes in heart failure and their relationship to arrhythmogenesis
Janse, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.018 · Cited by 302
Cleland, J., Pennell, D., Ray, S., Coats, A., Macfarlane, P., Murray, G., Mule, J. D., Vered, Z., & Lahiri, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13801-9 · Cited by 301
Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model
Mozaffarian, D., Anker, S. D., Anand, I., Linker, D. T., Sullivan, M. D., Cleland, J. G. F., Carson, P. E., Maggioni, A. P., Mann, D. L., Pitt, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.687103 · Cited by 301
Bushby, K., Muntoni, F., & Bourke, J. P. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00213-4 · Cited by 300
Swedberg, K., Pfeffer, M., Granger, C., Held, P., Mcmurray, J., Ohlin, G., Olofsson, B., Östergren, J., & Yusuf, S. (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)90013-1 · Cited by 294
Schaufelberger, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.12.012 · Cited by 292
Saxon, L. A., Bristow, M. R., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., Feldman, A. M., Galle, E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.642892 · Cited by 290
Groenning, B. A., Nilsson, J. C., Sondergaard, L., Fritz-Hansen, T., Larsson, H. B. W., & Hildebrandt, P. R. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01006-8 · Cited by 288
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.020 · Cited by 288
Holubarsch, C. J. F., Rohrbach, M., Karrasch, M., Boehm, E., Polonski, L., Ponikowski, P., & Rhein, S. (2007) · Clinical Science · doi:10.1042/cs20060307 · Cited by 287
Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction
Abraham, W. T., Zile, M. R., Weaver, F. A., Butter, C., Ducharme, A., Halbach, M., Klug, D., Lovett, E. G., Müller-Ehmsen, J., Schafer, J. E., et al. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.02.006 · Cited by 286
Therapeutic implications of the gender-specific aspects of cardiovascular disease
Regitz-Zagrosek, V. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2032 · Cited by 284
Olsson, L. G., Swedberg, K., Clark, A. L., Witte, K. K., & Cleland, J. G. F. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi162 · Cited by 284
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure
Wikstrand, J., Hjalmarson, Å. K., Waagstein, F., Fagerberg, B. J., Goldstein, S., Kjekshus, J., & Wedel, H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01970-8 · Cited by 283
Telomere Length of Circulating Leukocytes Is Decreased in Patients With Chronic Heart Failure
van der Harst, P., van der Steege, G., de Boer, R. A., Voors, A. A., Hall, A. S., Mulder, M. J., van Gilst, W. H., & van Veldhuisen, D. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.027 · Cited by 281
McGowan, J. H., & Cleland, J. G. F. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00248-5 · Cited by 279
High heart rate: a cardiovascular risk factor?
Cook, S., Togni, M., Schaub, M. C., Wenaweser, P., & Hess, O. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl259 · Cited by 279
Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-Blockers
O’Neill, J. O., Young, J. B., Pothier, C. E., & Lauer, M. S. (2005) · Circulation · doi:10.1161/01.cir.0000164270.72123.18 · Cited by 277
Simon, T., Mary-Krause, M., Funck-Brentano, C., & Jaillon, P. (2001) · Circulation · doi:10.1161/01.cir.103.3.375 · Cited by 276
Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline
Heart Failure Society of America (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.005 · Cited by 276
Packer, M., McMurray, J., Massie, B. M., Caspi, A., Charlon, V., Cohen-Solal, A., Kiowski, W., Kostuk, W., Krum, H., Levine, B., et al. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.05.006 · Cited by 275
Yancy, C. W., Januzzi, J. L., Allen, L. A., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Jessup, M., Lindenfeld, J., Maddox, T. M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.025 · Cited by 275
Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients
ALTER, P., WALDHANS, S., PLACHTA, E., MOOSDORF, R., & GRIMM, W. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00195.x · Cited by 274
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 274
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases
Jochmann, N., Stangl, K., Garbe, E., Baumann, G., & Stangl, V. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi397 · Cited by 272
Sudden Cardiac Death in Patients With Human Immunodeficiency Virus Infection
Tseng, Z. H., Secemsky, E. A., Dowdy, D., Vittinghoff, E., Moyers, B., Wong, J. K., Havlir, D. V., & Hsue, P. Y. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.024 · Cited by 269
Mitochondria in cardiac hypertrophy and heart failure
Rosca, M. G., Tandler, B., & Hoppel, C. L. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.09.002 · Cited by 267
Fonarow, G. C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1493 · Cited by 267
Doughty, R. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2712 · Cited by 264
Swedberg, K., Komajda, M., Böhm, M., Borer, J., Robertson, M., Tavazzi, L., & Ford, I. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.020 · Cited by 262
Yumino, D., Wang, H., Floras, J. S., Newton, G. E., Mak, S., Ruttanaumpawan, P., Parker, J. D., & Bradley, T. D. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.11.015 · Cited by 261
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure
Kotecha, D., Flather, M. D., Altman, D. G., Holmes, J., Rosano, G., Wikstrand, J., Packer, M., Coats, A. J. S., Manzano, L., Böhm, M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.001 · Cited by 261
Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000207 · Cited by 259
Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Sun, J. L., Yancy, C. W., & Young, J. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.048 · Cited by 257
“ontrolled, randomized clinical trials (3,4) have demontrated that certain beta-blockers (carvedilol, metoprolol uccinate, and bisoprolol) reduce total mortality by approxmately 35% in patients with symptomatic chronic HF and eft ventricular systolic dysfunction (LVSD).”
BackgroundBaumhäkel, M., Müller, U., & Böhm, M. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn041 · Cited by 258
Kühlkamp, V., Schirdewan, A., Stangl, K., Homberg, M., Ploch, M., & Beck, O. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00693-8 · Cited by 256
Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era
Huikuri, H. V., Tapanainen, J. M., Lindgren, K., Raatikainen, P., Mäkikallio, T. H., Juhani Airaksinen, K. E., & Myerburg, R. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00783-6 · Cited by 253
Kamat, A. M., Flaig, T. W., Grossman, H. B., Konety, B., Lamm, D., O'Donnell, M. A., Uchio, E., Efstathiou, J. A., & Taylor, J. A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.58 · Cited by 252
Barki-Harrington, L., Luttrell, L. M., & Rockman, H. A. (2003) · Circulation · doi:10.1161/01.cir.0000092166.30360.78 · Cited by 252
Givertz, M. M., Stevenson, L. W., Costanzo, M. R., Bourge, R. C., Bauman, J. G., Ginn, G., & Abraham, W. T. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.010 · Cited by 248
Hypertension and Heart Failure
Slivnick, J., & Lampert, B. C. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.06.007 · Cited by 242
Burnett, H., Earley, A., Voors, A. A., Senni, M., McMurray, J. J. V., Deschaseaux, C., & Cope, S. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003529 · Cited by 238
Cardiovascular Protection Using Beta-Blockers
Bangalore, S., Messerli, F. H., Kostis, J. B., & Pepine, C. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.060 · Cited by 233
Inotropic therapy for heart failure: An evidence-based approach
Felker, G. M., & O’Connor, C. M. (2001) · American Heart Journal · doi:10.1067/mhj.2001.117606 · Cited by 232
Zannad, F., Garcia, A. A., Anker, S. D., Armstrong, P. W., Calvo, G., Cleland, J. G. F., Cohn, J. N., Dickstein, K., Domanski, M. J., Ekman, I., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft095 · Cited by 231
Heart failure as an autonomic nervous system dysfunction
Kishi, T. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2011.12.006 · Cited by 227
Lindenfeld, J., Feldman, A. M., Saxon, L., Boehmer, J., Carson, P., Ghali, J. K., Anand, I., Singh, S., Steinberg, J. S., Jaski, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.629261 · Cited by 225
Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure
Brunner-La Rocca, H. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2407 · Cited by 224
Böhm, M., Young, R., Jhund, P. S., Solomon, S. D., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw570 · Cited by 219
Echocardiography in Heart Failure
Kirkpatrick, J. N., Vannan, M. A., Narula, J., & Lang, R. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.048 · Cited by 219
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial
Domanski, M., Krause-Steinrauf, H., Deedwania, P., Follmann, D., Ghali, J. K., Gilbert, E., Haffner, S., Katz, R., Lindenfeld, J., Lowes, B. D., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00856-8 · Cited by 215
Bay, M., Kirk, V, Parner, J., Hassager, C., Nielsen, H., Krogsgaard, K., Trawinski, J., Boesgaard, S., & Aldershvile, J. (2003) · Heart · doi:10.1136/heart.89.2.150 · Cited by 212
McKelvie, R. S., Moe, G. W., Ezekowitz, J. A., Heckman, G. A., Costigan, J., Ducharme, A., Estrella-Holder, E., Giannetti, N., Grzeslo, A., Harkness, K., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.10.007 · Cited by 208
The MERIT-HF Study Group, White, H. L., de Boer, R. A., Maqbool, A., Greenwood, D., van Veldhuisen, D. J., Cuthbert, R., Ball, S. G., Hall, A. S., & Balmforth, A. J. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00044-8 · Cited by 199
Piccini, J. P., Berger, J. S., & O'Connor, C. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp100 · Cited by 198
“This risk of sudden cardiac death (SCD) is most pronounced among patients with heart failure, in whom the 1 year absolute risk of SCD is between 4 and 13%.(1,2) The implantable cardioverter defibrillator (ICD) is an effective means of preventing SCD in patients with left ventricular dysfunction, however, its use is li…”
BackgroundGreenberg, B. H., Abraham, W. T., Albert, N. M., Chiswell, K., Clare, R., Stough, W. G., Gheorghiade, M., O'Connor, C. M., Sun, J. L., Yancy, C. W., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.05.001 · Cited by 196
Antzelevitch, C., Brugada, P., Brugada, J., Brugada, R., Towbin, J. A., & Nademanee, K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00310-3 · Cited by 196
Haas, S. J., Vos, T., Gilbert, R. E., & Krum, H. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00403-4 · Cited by 194
Lenzen, M. J., Boersma, E., Scholte op Reimer, W. J. M., Balk, A. H. M. M., Komajda, M., Swedberg, K., Follath, F., Jimenez-Navarro, M., Simoons, M. L., & Cleland, J. G. F. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi499 · Cited by 193
Erland, E., Philippe, L., Patricia, V., & Hermann, W. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00174-x · Cited by 190
Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure
Prins, K. W., Neill, J. M., Tyler, J. O., Eckman, P. M., & Duval, S. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.03.008 · Cited by 190
Cardiac Sympathetic Imaging With mIBG in Heart Failure
Carrió, I., Cowie, M. R., Yamazaki, J., Udelson, J., & Camici, P. G. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.07.014 · Cited by 189
Groenning, B. A., Raymond, I., Hildebrandt, P. R., Nilsson, J. C., Baumann, M., & Pedersen, F. (2004) · Heart · doi:10.1136/hrt.2003.026021 · Cited by 188
Cardiovascular drug therapy in the elderly: benefits and challenges
Fleg, J. L., Aronow, W. S., & Frishman, W. H. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.162 · Cited by 186
Pulignano, G., Del Sindaco, D., Tavazzi, L., Lucci, D., Gorini, M., Leggio, F., Porcu, M., Scherillo, M., Opasich, C., Di Lenarda, A., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.119608 · Cited by 184
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
Tsutsui, H., Ide, T., Ito, H., Kihara, Y., Kinugawa, K., Kinugawa, S., Makaya, M., Murohara, T., Node, K., Saito, Y., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0431 · Cited by 183
Colucci, W. S., Kolias, T. J., Adams, K. F., Armstrong, W. F., Ghali, J. K., Gottlieb, S. S., Greenberg, B., Klibaner, M. I., Kukin, M. L., & Sugg, J. E. (2007) · Circulation · doi:10.1161/circulationaha.106.666016 · Cited by 181
Reiken, S., Gaburjakova, M., Gaburjakova, J., He, K.-L., Prieto, A., Becker, E., Yi, G.-H., Wang, J., Burkhoff, D., & Marks, A. R. (2001) · Circulation · doi:10.1161/hc4701.099578 · Cited by 181
Antioxidant activity of carvedilol in cardiovascular disease
Dandona, P., Ghanim, H., & Brooks, D. P. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280127948 · Cited by 179
Metra, M., Torp-Pedersen, C., Swedberg, K., Cleland, J. G. F., Di Lenarda, A., Komajda, M., Remme, W. J., Lutiger, B., Scherhag, A., Lukas, M. A., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi386 · Cited by 178
Domanski, M. J., Krause-Steinrauf, H., Massie, B. M., Deedwania, P., Follmann, D., Kovar, D., Murray, D., Oren, R., Rosenberg, Y., Young, J., et al. (2003) · Journal of Cardiac Failure · doi:10.1054/s1071-9164(03)00133-7 · Cited by 176
G Protein-Coupled Receptors: A Century of Research and Discovery
Liu, S., Anderson, P. J., Rajagopal, S., Lefkowitz, R. J., & Rockman, H. A. (2024) · Circulation Research · doi:10.1161/circresaha.124.323067 · Cited by 176
Naccarelli, G. V., Wolbrette, D. L., Khan, M., Bhatta, L., Hynes, J., Samii, S., & Luck, J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03375-1 · Cited by 174
The Benefit of Implementing a Heart Failure Disease Management Program
Whellan, D. J., Gaulden, L., Gattis, W. A., Granger, B., Russell, S. D., Blazing, M. A., Cuffe, M. S., & O'Connor, C. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.18.2223 · Cited by 172
“Since these studies were conducted before there was strong evidence for -blocker use, none of them evaluated the benefit of disease management programs on improving rates of -blocker therapy.(14-16) We undertook this study to evaluate the potential benefit of implementing a ORIGINAL INVESTIGATION”
BackgroundTorp-Pedersen, C., Metra, M., Charlesworth, A., Spark, P., Lukas, M. A., Poole-Wilson, P. A., Swedberg, K., Cleland, J. G. F., Di Lenarda, A., Remme, W. J., et al. (2007) · Heart · doi:10.1136/hrt.2006.092379 · Cited by 171
β-Blockers in Chronic Heart Failure
Gheorghiade, M., Colucci, W. S., & Swedberg, K. (2003) · Circulation · doi:10.1161/01.cir.0000065187.80707.18 · Cited by 167
Iwata, M., Yoshikawa, T., Baba, A., Anzai, T., Mitamura, H., & Ogawa, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01109-8 · Cited by 165
Heart Failure Registry: A Valuable Tool for Improving the Management of Patients with Heart Failure
Jonsson, Å., Edner, M., Alehagen, U., & Dahlström, U. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp175 · Cited by 165
Ko, D. T., Hebert, P. R., Coffey, C. S., Curtis, J. P., Foody, J. M., Sedrakyan, A., & Krumholz, H. M. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1389 · Cited by 160
Demographics and concomitant disorders in heart failure
Krum, H., & Gilbert, R. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13869-x · Cited by 159
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.05.007 · Cited by 145
Deedwania, P. C., Giles, T. D., Klibaner, M., Ghali, J. K., Herlitz, J., Hildebrandt, P., Kjekshus, J., Spinar, J., Vitovec, J., Stanbrook, H., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.05.056 · Cited by 143
Lane, D. A., Aguinaga, L., Blomström-Lundqvist, C., Boriani, G., Dan, G.-A., Hills, M. T., Hylek, E. M., LaHaye, S. A., Lip, G. Y. H., Lobban, T., et al. (2015) · Europace · doi:10.1093/europace/euv233 · Cited by 142
Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández, A. V., Boersma, E., Murray, G. D., Habbema, J. D. F., & Steyerberg, E. W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.020 · Cited by 131
The agonising negative trend in monitoring of clinical trials
DeMets, D. L., Pocock, S. J., & Julian, D. G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03464-9 · Cited by 126
Taylor, A. L., Ziesche, S., Yancy, C. W., Carson, P., Ferdinand, K., Taylor, M., Adams, K., Olukotun, A. Y., Ofili, E., Tam, S. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.644013 · Cited by 114
Cygankiewicz, I., Zareba, W., Vazquez, R., Vallverdu, M., Gonzalez-Juanatey, J. R., Valdes, M., Almendral, J., Cinca, J., Caminal, P., & de Luna, A. B. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.04.017 · Cited by 113
Principles From Clinical Trials Relevant to Clinical Practice: Part I
Califf, R. M., & DeMets, D. L. (2002) · Circulation · doi:10.1161/01.cir.0000023260.78078.bb · Cited by 108
Metadata
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1999-06
- Volume
- 353
- Issue
- 9169
- Pages
- 2001-2007
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W52877415
- Cited by
- 5,129
- References
- 27
- FWCI
- 192.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.